Modeling of 82 brand drugs with ≥$100 million Medicaid spend found net prices exceeded at least one international reference ...
Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...
A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...
Analyses spanning 35,245 patients across 13 scenarios found comparable initiation of any systemic therapy in Medicare ...
A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...
FDA approval establishes enlicitide as the first oral PCSK9 inhibitor for low-density lipoprotein cholesterol reduction, positioning it as a daily alternative to injectable PCSK9 agents. The approved ...
Survivorship care and patient follow-up, being pivotal to managing treatment plans for patients with breast cancer, were key ...
In the final episode, 'Fixing the Mental Health System: Burnout, Advocacy, and the Case for Team-Based Care,' the panelists ...
This study examines how key players in managed care drive postacute home health referrals, identifying tensions, limited ...
INCA033989 showed encouraging spleen, anemia, and molecular responses in mutant calreticulin myelofibrosis, suggesting ...
Jennifer Sheng, MD, discusses how multidisciplinary collaboration, tumor boards, and coordinated care improve breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results